![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
n-based medical services company - US-based subsidiary Imaging Biometrics LLC says that US Food & Drug Administration ...
IQ-AI Limited 25 June 2024 June 25, 2024 IQ-AI Ltd ("IQ-AI" or the "Company") Imaging Biometrics Opens Expanded Access Program New cancer treatment with the potential to slow brain tumor...
IQ-AI Ltd on Friday said the clinical team has started a phase 2 protocol for its oncology-focused drug oral gallium ...
IQ-AI Limited 14 June 2024 June 14, 2024 IQ-AI Ltd ("IQ-AI" or the "Company") IQ-AI Reports Phase 1 Update and Shares Plans for Phase 2 Clinical Trial As the end of the Phase 1 clinical...
IQ-AI Limited 29 May 2024 IQ-AI Limited ("IQ-AI" or the "Company") Result of AGM IQ-AI Limited announces that at the annual general meeting of the Company held earlier today, all...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
IQ-AI Limited 23 May 2024 IQ-AI Ltd ("IQ-AI" or the "Company") Major East Coast Health System Chooses IB Nimble for Their Brain Metastases Program of Excellence Imaging Biometrics, LLC...
IQ-AI Ltd on Monday said its subsidiary, Imaging Biometrics LLC, received a second rare paediatric disease designatio ...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.2 | 18.1818181818 | 1.1 | 1.3 | 1.1 | 519794 | 1.28429049 | DE |
4 | 0.15 | 13.0434782609 | 1.15 | 1.3 | 1 | 491285 | 1.15170469 | DE |
12 | -0.35 | -21.2121212121 | 1.65 | 1.9 | 1 | 533468 | 1.31167394 | DE |
26 | -2 | -60.6060606061 | 3.3 | 3.3 | 1 | 735990 | 1.72566883 | DE |
52 | -1.7 | -56.6666666667 | 3 | 5.75 | 1 | 903816 | 3.19762176 | DE |
156 | -6.2 | -82.6666666667 | 7.5 | 7.755 | 1 | 656295 | 3.83465194 | DE |
260 | -3.45 | -72.6315789474 | 4.75 | 22.75 | 1 | 1369894 | 7.31665573 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions